AI-assisted placenta pathology in clinical use: Barriers and opportunities

Placental pathology provides critical diagnostic information following pregnancy complications and has the potential to inform mother and infant clinical care. Yet the field faces substantial challenges, including workforce shortages, high inter-observer variability, inconsistent reporting, and ongoing debate regarding clinical utility. Artificial intelligence (AI) and computer vision methods offer potential solutions through automated analysis of both gross photography and digital histology. Recent studies demonstrate technical feasibility across tasks including gestational age prediction, cellular and structural quantification, and lesion detection. Near-term clinical applications should prioritise standardising measurements, reducing inter-observer variability, and accelerating report generation through assistive workflows to deliver timely results for clinical decision-making. Over the longer term, AI-derived placental phenotypes could enable prognostic research linking placental features to maternal and childhood outcomes, supporting a shift from diagnostic to prognostic clinical pathways. However, significant barriers impede clinical translation. These include the infrastructure and deployment costs associated with digital pathology and AI, regulatory requirements, and challenges specific to placenta pathology such as limited open-source datasets, indication bias in clinical samples, difficulty integrating information across placental compartments, inconsistent data linkage, and uncertainty regarding which features should be measured. Together, these factors contribute to high development costs and limit the availability of clinically deployable models. This review examines both the opportunities for AI and computer vision in placental pathology and the barriers to their translation, and proposes priorities for the pathology community. Addressing these priorities would position AI to transform placental pathology from a resource-limited diagnostic service into a scalable, data-driven discipline that improves immediate clinical care and enables discovery-driven advances in maternal and child health.

Authors

Institutions

Publication Details

Journal
Placenta
Published
2026-05-01
DOI
https://doi.org/10.1016/j.placenta.2026.05.006
Primary Topic
AI in cancer detection
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AI-assisted placenta pathology in clinical use: Barriers and opportunities

Craig A. Glastonbury, Abigail Fraser, Linda M. Ernst, Kenton O’Hara et al.
Placenta
AI in cancer detection
article

AI-assisted placenta pathology in clinical use: Barriers and opportunities

Craig A. Glastonbury, Abigail Fraser, Linda M. Ernst, Kenton O’Hara, Emma Clare Walker, Christoffer Nellaker, Yiwen Huang, Sanne J. Gordijn
article en

Abstract

Placental pathology provides critical diagnostic information following pregnancy complications and has the potential to inform mother and infant clinical care. Yet the field faces substantial challenges, including workforce shortages, high inter-observer variability, inconsistent reporting, and ongoing debate regarding clinical utility. Artificial intelligence (AI) and computer vision methods offer potential solutions through automated analysis of both gross photography and digital histology. Recent studies demonstrate technical feasibility across tasks including gestational age prediction, cellular and structural quantification, and lesion detection. Near-term clinical applications should prioritise standardising measurements, reducing inter-observer variability, and accelerating report generation through assistive workflows to deliver timely results for clinical decision-making. Over the longer term, AI-derived placental phenotypes could enable prognostic research linking placental features to maternal and childhood outcomes, supporting a shift from diagnostic to prognostic clinical pathways. However, significant barriers impede clinical translation. These include the infrastructure and deployment costs associated with digital pathology and AI, regulatory requirements, and challenges specific to placenta pathology such as limited open-source datasets, indication bias in clinical samples, difficulty integrating information across placental compartments, inconsistent data linkage, and uncertainty regarding which features should be measured. Together, these factors contribute to high development costs and limit the availability of clinically deployable models. This review examines both the opportunities for AI and computer vision in placental pathology and the barriers to their translation, and proposes priorities for the pathology community. Addressing these priorities would position AI to transform placental pathology from a resource-limited diagnostic service into a scalable, data-driven discipline that improves immediate clinical care and enables discovery-driven advances in maternal and child health.

Placenta
University Medical Center Groningen (NL), University of Groningen (NL), University of Bristol (GB), University of Oxford (GB), University of Chicago (US), Human Technopole (IT), Oxford BioMedica (United Kingdom) (GB)
Wellcome Trust, UK Research and Innovation, Fondation Leducq, Medical Research Council, Engineering and Physical Sciences Research Council
Zero hunger
Openalex Percentile: Top 7%
AI in cancer detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.